Test Directory

Test Code
1674
Test Name
Thrombocytopenia And Absent Radius Syndrome
CPT Codes
81479
Expected Turnaround Time
Typically 2 to 4 weeks from receipt of a sample in the laboratory. All cases involving ongoing pregnancies will be expedited.
Clinical Utility
Genetic analysis to provide a molecular diagnosis of this disorder. Recommended for individuals with a personal and/or family history of this disorder to ensure appropriate treatment and establish recurrence risk for family members.
Specimen and Container Info

Non-Prenatal Specimens

Preferred/Alternate

Specimen Type

Containers

Volume

Preferred Specimen Type

Whole Blood

Lavender Top (EDTA)

3 mL

Alternate Specimen Type

Genomic DNA

1.5 mL Tube

3 µg (at a concentration of at least 30 ng/µl), preferably in TE solution.

Alternate Specimen Type

Fibroblasts

T-25 Flasks

2 confluent T-25 flasks, filled to capacity

Alternate Specimen Type

Saliva (Whole blood is recommended for CNV)

DNA Self-Collection Kit or Oragene Saliva Collection Kit for Young Children

Follow kit instructions (www.dnagenotek.com)

Prenatal Specimens

Either specimen type below is acceptable.

Specimen Type

Containers

Volume

Cultured cells

T-25 Flasks

2 confluent T-25 flasks derived from amnio or CVS samples.

Genomic DNA

1.5 mL Tube

3 µg (at a concentration of at least 30 ng/µl), preferably in TE solution.

NOTE: For specimens from outside of North America, the preferred specimen type is Genomic DNA. HNL Genomics does not recommend shipping whole blood or cultured cells from any location other than the United States, Canada, or Mexico.

Transport Instructions
  • Transport at room temperature within 24 hours.
  • If the specimen cannot be transported to the lab within 24 hours, refrigerate for up to 72 hours.
  • Do not freeze or expose to extreme temperatures, refrigerate for up to 72 hours if cannot be transported to lab within 24 hours. 
Stability Requirements

Room Temperature

24 hours

Refrigerated

72 hours

Causes for Rejection
  • Improperly labeled specimen (minimum of two patient identifiers)
  • Inappropriate specimen type
  • Incomplete or incorrect test request form
  • Insufficient volume
  • Specimen has leaked in transit
  • Specimen without a test order
Methodology
Next Generation Sequencing and Copy Number Variation Analysis
Performing Location
Genomics - Snowdrift
Alternate Names
TAR
Description

Thrombocytopenia and absent radius syndrome (TAR; MIM 274000) is an autosomal recessive, frequently fatal disorder, caused by mutations in RNA-Binding Motif Protein 8A (RBM8A). The main characteristics of TAR are transient bleeding episodes early in life and upper limb abnormalities that vary from absence of radii to aplasia of the ulna and humerus. In severe cases the hands arises directly from the shoulder and may themselves display abnormal structure. Bleeding, which decreases in frequency and severity with advancing age, is caused by thrombocytopenia due to decreased numbers of bone marrow megakaryocytes. Transient leukocytosis has also been noted. Additional skeletal abnormalities may be present. These most commonly include: hip dysplasia, knee subluxation and coxa valga. Extraskeletal manifestations including tetralogy of Fallot, atrial and ventricular septal defects, coarctation of the aorta and genitourinary anomalies have been described. The vast majority of TAR cases are caused by a heterozygous deletion of about 200kb on chromosome 1q21.1, including the RBM8A gene, and one of two low frequency SNPs in the regulatory region of the same gene. In rare instances, one of the two RBM8A regulatory SNPs have been documented to be associated with a different, second compound heterozygous RBM8A null mutation other than the 200kb deletion. The described combinations of these compound heterozygous mutations account for more than 90% of TAR cases. RBM8A encodes the Y14 subunit of the exon-junction complex. This complex performs several essential RNA processing tasks including nuclear export and subcellular localization of transcripts, translational enhancement and nonsense-mediated RNA decay.

Testing Schedule
Monday-Friday
Genes
RBM8A
MIM
274000
Disease Group
Hematological, Skeletal Disorders